These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis. Lannagan TRM; Lee YK; Wang T; Roper J; Bettington ML; Fennell L; Vrbanac L; Jonavicius L; Somashekar R; Gieniec K; Yang M; Ng JQ; Suzuki N; Ichinose M; Wright JA; Kobayashi H; Putoczki TL; Hayakawa Y; Leedham SJ; Abud HE; Yilmaz ÖH; Marker J; Klebe S; Wirapati P; Mukherjee S; Tejpar S; Leggett BA; Whitehall VLJ; Worthley DL; Woods SL Gut; 2019 Apr; 68(4):684-692. PubMed ID: 29666172 [TBL] [Abstract][Full Text] [Related]
3. Mutant BRAF Upregulates MCL-1 to Confer Apoptosis Resistance that Is Reversed by MCL-1 Antagonism and Cobimetinib in Colorectal Cancer. Kawakami H; Huang S; Pal K; Dutta SK; Mukhopadhyay D; Sinicrope FA Mol Cancer Ther; 2016 Dec; 15(12):3015-3027. PubMed ID: 27765849 [TBL] [Abstract][Full Text] [Related]
4. BRAF Sakamoto N; Feng Y; Stolfi C; Kurosu Y; Green M; Lin J; Green ME; Sentani K; Yasui W; McMahon M; Hardiman KM; Spence JR; Horita N; Greenson JK; Kuick R; Cho KR; Fearon ER Elife; 2017 Jan; 6():. PubMed ID: 28072391 [TBL] [Abstract][Full Text] [Related]
6. Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer. Dietinger V; García de Durango CR; Wiechmann S; Boos SL; Michl M; Neumann J; Hermeking H; Kuster B; Jung P Cell Commun Signal; 2020 Jun; 18(1):102. PubMed ID: 32586342 [TBL] [Abstract][Full Text] [Related]
7. Serine-threonine Kinase Receptor-Associated Protein is a Critical Mediator of APC Mutation-Induced Intestinal Tumorigenesis Through a Feed-Forward Mechanism. Vu T; Datta A; Banister C; Jin L; Yuan G; Samuel T; Bae S; Eltoum IE; Manne U; Zhang B; Welner RS; Mitra K; Buckhaults P; Datta PK Gastroenterology; 2022 Jan; 162(1):193-208. PubMed ID: 34520730 [TBL] [Abstract][Full Text] [Related]
8. Intestinal cancer progression by mutant p53 through the acquisition of invasiveness associated with complex glandular formation. Nakayama M; Sakai E; Echizen K; Yamada Y; Oshima H; Han TS; Ohki R; Fujii S; Ochiai A; Robine S; Voon DC; Tanaka T; Taketo MM; Oshima M Oncogene; 2017 Oct; 36(42):5885-5896. PubMed ID: 28628120 [TBL] [Abstract][Full Text] [Related]
9. Aging-like Spontaneous Epigenetic Silencing Facilitates Wnt Activation, Stemness, and Braf Tao Y; Kang B; Petkovich DA; Bhandari YR; In J; Stein-O'Brien G; Kong X; Xie W; Zachos N; Maegawa S; Vaidya H; Brown S; Chiu Yen RW; Shao X; Thakor J; Lu Z; Cai Y; Zhang Y; Mallona I; Peinado MA; Zahnow CA; Ahuja N; Fertig E; Issa JP; Baylin SB; Easwaran H Cancer Cell; 2019 Feb; 35(2):315-328.e6. PubMed ID: 30753828 [TBL] [Abstract][Full Text] [Related]
10. A genetic progression model of Braf(V600E)-induced intestinal tumorigenesis reveals targets for therapeutic intervention. Rad R; Cadiñanos J; Rad L; Varela I; Strong A; Kriegl L; Constantino-Casas F; Eser S; Hieber M; Seidler B; Price S; Fraga MF; Calvanese V; Hoffman G; Ponstingl H; Schneider G; Yusa K; Grove C; Schmid RM; Wang W; Vassiliou G; Kirchner T; McDermott U; Liu P; Saur D; Bradley A Cancer Cell; 2013 Jul; 24(1):15-29. PubMed ID: 23845441 [TBL] [Abstract][Full Text] [Related]
11. Oncogenic mutation in RAS-RAF axis leads to increased expression of GREB1, resulting in tumor proliferation in colorectal cancer. Kochi M; Hinoi T; Niitsu H; Miguchi M; Saito Y; Sada H; Sentani K; Sakamoto N; Oue N; Tashiro H; Sotomaru Y; Yasui W; Ohdan H Cancer Sci; 2020 Oct; 111(10):3540-3549. PubMed ID: 32629543 [TBL] [Abstract][Full Text] [Related]
12. Role of BRAF-V600E in the serrated pathway of colorectal tumourigenesis. Minoo P; Moyer MP; Jass JR J Pathol; 2007 Jun; 212(2):124-33. PubMed ID: 17427169 [TBL] [Abstract][Full Text] [Related]
13. Chromosome Engineering of Human Colon-Derived Organoids to Develop a Model of Traditional Serrated Adenoma. Kawasaki K; Fujii M; Sugimoto S; Ishikawa K; Matano M; Ohta Y; Toshimitsu K; Takahashi S; Hosoe N; Sekine S; Kanai T; Sato T Gastroenterology; 2020 Feb; 158(3):638-651.e8. PubMed ID: 31622618 [TBL] [Abstract][Full Text] [Related]
14. The intermediate-activity (L597V)BRAF mutant acts as an epistatic modifier of oncogenic RAS by enhancing signaling through the RAF/MEK/ERK pathway. Andreadi C; Cheung LK; Giblett S; Patel B; Jin H; Mercer K; Kamata T; Lee P; Williams A; McMahon M; Marais R; Pritchard C Genes Dev; 2012 Sep; 26(17):1945-58. PubMed ID: 22892241 [TBL] [Abstract][Full Text] [Related]
15. Lkb1 loss promotes tumor progression of BRAF(V600E)-induced lung adenomas. González-Sánchez E; Martín-Caballero J; Flores JM; Hernández-Losa J; ; Cortés J; Mares R; Barbacid M; Recio JA PLoS One; 2013; 8(6):e66933. PubMed ID: 23825589 [TBL] [Abstract][Full Text] [Related]
17. APC mutations in human colon lead to decreased neuroendocrine maturation of ALDH+ stem cells that alters GLP-2 and SST feedback signaling: Clue to a link between WNT and retinoic acid signalling in colon cancer development. Zhang T; Ahn K; Emerick B; Modarai SR; Opdenaker LM; Palazzo J; Schleiniger G; Fields JZ; Boman BM PLoS One; 2020; 15(10):e0239601. PubMed ID: 33112876 [TBL] [Abstract][Full Text] [Related]
18. Co-existence of BRAF V600E Gene Mutation in Tumor and Non-tumoral Surrounding Tissues in Colorectal Cancer. Öztürk T; Toptaş-Hekimoğlu B; Eronat AP; Saygili N; Dağlar-Aday A; Başsüllü N; Türkmen I; Aydoğan HY; Bülbül G; Göksel S; Öztürk O; Isbir T In Vivo; 2015; 29(5):577-84. PubMed ID: 26359417 [TBL] [Abstract][Full Text] [Related]
19. Targeting CDK1 and MEK/ERK Overcomes Apoptotic Resistance in BRAF-Mutant Human Colorectal Cancer. Zhang P; Kawakami H; Liu W; Zeng X; Strebhardt K; Tao K; Huang S; Sinicrope FA Mol Cancer Res; 2018 Mar; 16(3):378-389. PubMed ID: 29233910 [TBL] [Abstract][Full Text] [Related]